NPPA unit to monitor drug pricing set up in J-K

Srinagar (Jammu and Kashmir) [India], April 1 (ANI): The National Pharmaceutical Pricing Authority (NPPA) has set up...

Lockdown effect: Emergency wards across country see surge in...

New Delhi [India], April 1 (ANI): Amid a lockdown in the country to prevent the spread of coronavirus, health...

G-20 leaders pledge support in fight against COVID-19

Riyadh [Saudi Arabia], Mar 31 (ANI): Trade ministers from the Group of 20 (G-20) major economies have agreed to...

COVID-19 lockdown: Delhi Drug Traders Association distributes...

New Delhi [India], Mar 30 (ANI): Amid nationwide lockdown, the Delhi Drug Traders Association on Monday distributed...

Intas contributes for the global trials against COVID-19

Ahmedabad (Gujarat) [India], Mar 30 (ANI/ PRNewswire): Intas Pharmaceuticals Ltd., the largest supplier by volume...

Strides announces successful completion of US FDA inspection...

Bengaluru (Karnataka) [India], Mar 30 (ANI): Strides Pharma Science Ltd said on Monday it has received the...

'Enough stock of sanitisers, gloves, masks, don't have...

New Delhi [India], Mar 28 (ANI): There is enough stock of hand sanitisers, gloves and masks but there is lack of...

Not enough passes for staff of medicine shop owners: Delhi...

New Delhi [India], Mar 28 (ANI): Medicines shops in Delhi are facing a shortage of staff due to the...

COVID-19 : Punjab distilleries begins manufacturing sanitisers

Chandigarh (Punjab) [India], Mar 28 (ANI): The distilleries in Punjab have started manufacturing sanitizers on the...

Ludhiana faces medicine shortage as wholesale supply stops

Ludhiana (Punjab) [India], Mar 28 (ANI): Drug shortage in medical stores across Ludhiana as medical store owners in...

How trans fats assist cell death

Washington D.C. [USA], Mar 28 (ANI): A molecular link between some trans fats and a variety of disorders, including...

Cipla receives final approval for generic version of...

Mumbai (Maharashtra) [India], Mar 27 (ANI/ PRNewswire): Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter...